Senseonics Holdings Inc (NASDAQ:SENS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Thursday.

According to Zacks, “Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. “

Senseonics Holdings (NASDAQ:SENS) opened at 2.91 on Thursday. The company has a 50 day moving average price of $2.73 and a 200-day moving average price of $3.49. The firm’s market capitalization is $271.76 million. Senseonics Holdings has a 52 week low of $2.17 and a 52 week high of $4.24.

TRADEMARK VIOLATION NOTICE: This story was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another website, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2016/11/28/senseonics-holdings-inc-sens-rating-increased-to-hold-at-zacks-investment-research.html.

About Senseonics Holdings

Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.

5 Day Chart for NASDAQ:SENS

Receive News & Stock Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related stocks with our FREE daily email newsletter.